Logo

1health: Mostafa Ronaghi

Feb 16, 2021

Testing-as-a-service company 1health has appointed Mostafa Ronaghi to its board of directors. Ronaghi was chief technology and senior vice president at Illumina for about 13 years. He also cofounded the Illumina Accelerator and spinoff company Grail. Ronaghi also cofounded several other genomics and life science data ventures, including Avantome, ParAllele Bioscience, NextBio, and Pyrosequencing. Prior to these ventures, he was a principal investigator at Stanford University from 1999 to 2008, focusing on the development of molecular diagnostic applications.

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.